Similar articles

• European guidelines on cardiovascular disease and prevention in clinical practice.

  De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Third Joint Force of European and other Societies on Cardiovascular Disease and Prevention in Clinical Practice. De Backer G, et al. Atherosclerosis. 2003 Nov;171(1):145-55. doi: 10.1016/j.atherosclerosis.2003.10.001. Atherosclerosis. 2003. Corrected and republished in: Atherosclerosis. 2004 Apr;173(2):381-91. PMID: 14686332 Corrected and republished. No abstract available.
• Reducing the cardiovascular disease burden: justified means for getting to the end.

  Bikdeli B, Barreto-Filho JA. Bikdeli B, et al. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):580-6. doi: 10.1161/CIRCOUTCOMES.111.964072. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22811501 No abstract available.
• Editor's presentation.

  Piepoli MF. Piepoli MF. Eur J Prev Cardiol. 2018 Mar;25(4):339-341. doi: 10.1177/2047487318759854. Eur J Prev Cardiol. 2018. PMID: 29446663 No abstract available.
• Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention.

  Lombardi M, Mercuro G, Fini M, Rosano GM. Lombardi M, et al. Fundam Clin Pharmacol. 2010 Dec;24(6):699-705. doi: 10.1111/j.1472-8206.2010.00834.x. Fundam Clin Pharmacol. 2010. PMID: 20584207 Review.
• Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews.

  Studziński K, Tomasik T, Krzysztoń J, Jóźwiak J, Windak A. Studziński K, et al. BMC Cardiovasc Disord. 2019 Jan 9;19(1):11. doi: 10.1186/s12872-018-0990-2. BMC Cardiovasc Disord. 2019. PMID: 30626326 Free PMC article. Review.